Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001377669 | SCV001575057 | likely pathogenic | Majeed syndrome | 2023-08-17 | criteria provided, single submitter | clinical testing | A similar copy number variant has been observed in individuals with Majeed syndrome (PMID: 33314777; Invitae). This variant disrupts a region of the LPIN2 protein in which other variant(s) (p.Ser734Leu) have been observed in individuals with LPIN2-related conditions (PMID: 15994876). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is a gross deletion of the genomic region encompassing exon(s) 7-18 of the LPIN2 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |